Literature DB >> 8942603

Opioid neurotoxicity: fentanyl dose-response effects in rats.

W A Kofke1, R H Garman, R L Stiller, M E Rose, R Garman.   

Abstract

Opioids, when administered in large doses, produce brain damage, primarily in the limbic system and association areas in rats. This investigation examined the relationship between opioid dose and severity and frequency of brain damage in rats. Forty male Sprague-Dawley rats were anesthetized with halothane/N2O and underwent tracheal intubation, mechanical ventilation, arterial/venous cannulation, and insertion of a rectal temperature probe and biparietal electroencephalogram electrodes. After surgery, halothane was discontinued and O2/N2O 30%/70% was administered for 1 h. Rats were then randomly assigned to one of eight groups. The control group received a loading dose (LD) of 4 mL/kg of 0.9% normal saline solution (NSS) and a maintenance dose (MD) of 4 mL.kg-1.h-1 NSS. The other groups were given fentanyl lypophilized and reconstituted in NSS with the LD ranging from 50 to 3200 micrograms/kg and the MD from 2 to 128 micrograms.kg-1.min-1. After 2 h of fentanyl or NSS infusion; all rats received 100% O2 and, when alert, their tracheas were extubated; after 7 days the rats underwent cerebral perfusion fixation, followed by light microscopic evaluation. Histopathologic lesions (primarily eosinophilic neuron degeneration) were subjectively graded by a pathologist unaware of the experimental treatment; the grades were based on the percentage of dead neurons. There were no lesions observed in the brain areas in any of the control or 200-8 (LD, microgram/kg; MD, microgram.kg-1.min-1) groups. Eleven of 20 rats in the 400-16, 800-32, 1600-64, and 3200-18 groups showed evidence of brain damage primarily in limbic system structures and association areas (P < 0.05). Our data confirm that fentanyl produces limbic system brain damage in rats, and that the damage occurs over a broad range of doses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942603     DOI: 10.1097/00000539-199612000-00029

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  12 in total

1.  Opioid-associated amnestic syndrome observed with fentanyl patch use.

Authors:  Ryan G Taylor; Adrian Budhram; Donald H Lee; Seyed M Mirsattari
Journal:  CMAJ       Date:  2019-03-25       Impact factor: 8.262

2.  Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro.

Authors:  J A Gurwell; A Nath; Q Sun; J Zhang; K M Martin; Y Chen; K F Hauser
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

3.  Effect of fentanyl on ischemic depolarization and ischemic neuronal damage of hippocampal CA1 in the gerbil.

Authors:  Kensuke Shiraishi; Yoshimasa Takeda; Kenichi Masui; Hideki Taninishi; Toshihiro Sasaki; Tetsuya Danura; Kiyoshi Morita
Journal:  J Anesth       Date:  2011-04-21       Impact factor: 2.078

4.  Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment.

Authors:  James Prosser; Lisa J Cohen; Matthew Steinfeld; Daniel Eisenberg; Edythe D London; Igor I Galynker
Journal:  Drug Alcohol Depend       Date:  2006-03-20       Impact factor: 4.492

5.  A Comparison of Buprenorphine, Sustained release Buprenorphine, and High concentration Buprenorphine in Male New Zealand White Rabbits.

Authors:  David D Andrews; Virginia R Fajt; Kate C Baker; Robert V Blair; Sean H Jones; Georgina L Dobek
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-07-16       Impact factor: 1.232

6.  Temporal Changes in Caspase-1 and Caspase-8 Activities Following Brain Hypoxia With and Without Src kinase Inhibition in a Piglet Animal Model.

Authors:  Dimitrios Angelis; Tania D Fontánez Nieves; Maria Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2015-09-05       Impact factor: 3.996

7.  Lasting developmental effects of neonatal fentanyl exposure in preweanling rats.

Authors:  Dora Catré; Maria Francelina Lopes; António Silvério Cabrita
Journal:  Anesthesiol Res Pract       Date:  2011-10-19

8.  Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers.

Authors:  Jonathan Polussa; Andrea Schneider; Randi Hagerman
Journal:  Brain Disord Ther       Date:  2014

9.  Electrocortical changes associating sedation and respiratory depression by the opioid analgesic fentanyl.

Authors:  Gaspard Montandon; Richard L Horner
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

10.  Pharmacokinetics of dexmedetomidine combined with therapeutic hypothermia in a piglet asphyxia model.

Authors:  M Ezzati; K Broad; G Kawano; S Faulkner; J Hassell; B Fleiss; P Gressens; I Fierens; J Rostami; M Maze; J W Sleigh; B Anderson; R D Sanders; N J Robertson
Journal:  Acta Anaesthesiol Scand       Date:  2014-04-13       Impact factor: 2.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.